Accumulating evidence has shown that SRC-3 is involved in initiation, progression and metastasis in numerous cancer types by promoting cell proliferation and resisting apoptosis through both nuclear receptor-dependent and/or -independent pathways (19–21). Here, NCOA3 is linked to cancer.